Sunday, January 16, 2022
HomeBusinessBiofortuna looks to double in size after move to new Deeside HQ

Biofortuna looks to double in size after move to new Deeside HQ

NORTH West biotech company, Biofortuna, has set out plans to double the size of its team after investing in a new headquarters and manufacturing facility in Deeside.

The company, which specialises in developing and manufacturing diagnostic tests for a number of conditions, ranging from lung cancer to COVID, expects to double its headcount from 30 to more than 60 over the next two years as result of its investment.

Backed by Foresight Group, the leading SME investor, Biofortuna has relocated from Brombrough, Wirral, to a purpose-built, facility at Deeside Industrial Park to which has more than doubled capacity and includes a class-leading, humidity-controlled clean room for manufacturing more than 10 million tests per week.

The new jobs will include roles across the whole business including laboratory roles in assay development and manufacturing and commercial roles in project management and sales.

Biofortuna has particular expertise in assay stabilisation; techniques that enable diagnostic tests to be transported and stored at room temperature without the need for expensive and energy inefficient refrigeration and freezing.

Chief Executive Officer Dr Nick Ash said: “This multi-million-pound investment demonstrates our ambition and commitment to become the sector’s leading support specialist, helping our customers to accelerate their diagnostic development programmes from concept to commercialisation.”

Head of Sales Paul Williams added: “This facility will position Biofortuna as one of the leading outsourced providers of genomic services, custom assay development and contract manufacturing.”

David Turner, Director, Foresight Group added “We are delighted to see the progress made by our portfolio company, Biofortuna and the delivery of their growth strategy. 

“The opening of this impressive facility will help position Biofortuna as the leading provider of contract development and manufacturing services to the global in vitro Diagnostic and Point of Care sectors for many years to come”.

Biofortuna was assisted with the property search by Chester based Chartered Surveyors Legat Owen and with the legal contracting and conveyancing by Shoosmiths, Manchester.

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments